JPRN-UMIN000017170Completed未知
A multicenter pilot study of antithymocyte globulin in patients undergoing allogeneic peripheral blood stem cell transplantation - NJHSG-ATG
orth Japan Hematology Study Group (NJHSG)0 sites6 target enrollmentStarted: April 19, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 6
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 16years-old to 65years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Patients who are positive for HBs antigen or HIV antibody. 2. Patients with severe mental illness 3. Women who are pregnant, of childbearing potential, or lactating. 4. Patients with active other malignancies. 5. Patients with active infectious disease. 6. Patients who had a history of myocardial infarction, or who needed treatment for heart failure within 1 year. 7. Patients with cirrhosis 8. Obese patients (body mass index [BMI; 35 or greater]) 9. Patients with arrhythmia (CTCAE Grade 3 or more) 10. Patients who experienced serious hypersensitivity or anaphylaxis to antithymocyte globulin. 11. Patients who are not eligible for this study at the discretion of the investigator.
Investigators
Similar Trials
Not yet recruiting
Phase 2
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 BlockadeGraft-versus-host DiseaseHematological MalignanciesNCT06238245Beijing 302 Hospital22
Active, not recruiting
Phase 1
Prospective Phase II study of Rabbit Antithymocyte globulin (ATG, Thymoglobuline®, Genzyme) with Ciclosporin for Patients with Acquired Aplastic Anaemia and comparison with matched historical patients treated with horse ATG and CiclosporiAcquired severe aplastic anaemia and transfusion dependent non-severe aplastic anaemiaMedDRA version: 14.0 Level: LLT Classification code 10002274 Term: Anemia aplastic System Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2007-000902-55-GBEBMT (European group for Blood and Marrow Transplantation)35
Not yet recruiting
Not Applicable
The effects of antithymocyte globulin (ATG) on the endothelial glycocalyx in kidney transplant recipientsendothelial glycocalyx and atherosclerosis1003843010003216NL-OMON34735Academisch Medisch Centrum6
Not yet recruiting
Unknown
Studying antithyroglobulin antibodies in hashimotos disease with murphy repertoryCTRI/2024/03/063729il
Completed
Phase 4
Simulect Versus ATG in Sensitized Renal Transplant PatientRenal Transplant RejectionNCT02377193University Hospital, Toulouse60